Humoral immunity against Covid-19 six months after the Pfizer BNT162b2 vaccine in hemodialysis patients: data from five dialysis units. Is there a protective role for hemodiafiltration in the Covid-19 pandemic?

[1]  R. Gansevoort,et al.  Loss of humoral response 3 months after SARS-CoV-2 vaccination in the CKD spectrum: the multicentric SENCOVAC study , 2022, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  A. Leiba,et al.  Diminished and waning immunity to COVID-19 vaccination among hemodialysis patients in Israel: the case for a third vaccine dose , 2021, Clinical kidney journal.

[3]  M. Haase,et al.  Time-dependent evolution of IgG antibody levels after first and second dose of mRNA-based SARS-CoV-2 vaccination in hemodialysis patients: a multicenter study , 2021, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[4]  M. Bots,et al.  Online hemodiafiltration reduces systemic inflammation compared to low-flux hemodialysis. , 2014, Kidney international.

[5]  F. Fonseca,et al.  Hemodialysis and hepatitis B vaccination: a challenge to physicians , 2014, International journal of general medicine.